Methods in cancer epigenetics and epidemiology

Methods in Molecular Biology

Volumn 471, Issue , 2009, Pages 273-288

  Kumar, Deepak ^a   Verma, Mukesh ^b  

^a UNIVERSITY OF THE DISTRICT OF COLUMBIA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Acetylation; Biomarker; Chromatin; Epigenetics; Histone; Histone acetyl transferase (HAT); Histone deacetylase (HDAC); Methyl transferase; Methylation; Risk assessment; Screening

Indexed keywords

ARTICLE; GENETIC EPIGENESIS; GENETICS; HUMAN; MASS SCREENING; NEOPLASM; RISK ASSESSMENT;

EPIGENESIS, GENETIC; HUMANS; MASS SCREENING; NEOPLASMS; RISK ASSESSMENT;

EID: 60349126818     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-416-2_14     Document Type: Article

References (17)

1. Jones, P. A., and Baylin, S. B. (2007) The epigenomics of cancer. Cell 128, 683-692.
2. Jones, P. A., and Martienssen, R. (2005) A blueprint for a Human Epigenome Project: the AACR Human Epigenome Workshop. Cancer Res 65, 11241-11246.
3. Marjoram, P., Chang, J., Laird, P. W., and Siegmund, K. D. (2006) Cluster analysis for DNA methylation profiles having a detection threshold. BMC bioinformatics 7, 361.
4. Siegmund, K. D., Levine, A. J., Chang, J., and Laird, P. W. (2006) Modeling exposures for DNA methylation profiles. Cancer Epidemiol Biomarkers Prev 15, 567-572.
5. Verma, M., Seminara, D., Arena, F. J., John, C., Iwamoto, K., and Hartmuller, V. (2006) Genetic and epigenetic biomarkers in cancer: improving diagnosis, risk assessment, and disease stratification. Mol Diagn Ther 10, 1-15.
6. Eads, C. A., Danenberg, K. D., Kawakami, K., Saltz, L. B., Blake, C., Shibata, D., Danenberg, P. V., and Laird, P. W. (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28, E32.
7. Fiegl, H., Millinger, S., Goebel, G., Muller-Holzner, E., Marth, C., Laird, P. W., and Widschwendter, M. (2006) Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer. Cancer Res 66, 29-33.
8. Eads, C. A., Lord, R. V., Wickramasinghe, K., Long, T. I., Kurumboor, S. K., Bernstein, L., Peters, J. H., DeMeester, S. R., DeMeester, T. R., Skinner, K. A., and Laird, P. W. (2001) Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 61, 3410-3418.
9. Genereux, D. P., Miner, B. E., Bergstrom, C. T., and Laird, C. D. (2005) A population-epigenetic model to infer site-specific methylation rates from double-stranded DNA methylation patterns. Proc Natl Acad Sci U S A 102, 5802-5807.
10. Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., and Laird, P. W. (2007) Epigenetic stem cell signature in cancer. Nat Genet 39, 157-158.
11. Burden, A. F., Manley, N. C., Clark, A. D., Gartler, S. M., Laird, C. D., and Hansen, R. S. (2005) Hemimethylation and non-CpG methylation levels in a promoter region of human LINE-1 (L1) repeated elements. J Biol Chem 280, 14413-14419.
12. Stoger, R., Kajimura, T. M., Brown, W. T., and Laird, C. D. (1997) Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1. Hum Mol Genet 6, 1791-1801.
13. Anton, M., Horky, M., Kuchtickova, S., Vojtesek, B., and Blaha, O. (2004) Immunohistochemical detection of acetylation and phosphorylation of histone H3 in cervical smears. Ceska Gynekol 69, 3-6.
14. Allison, S. J., and Milner, J. (2003) Loss of p53 has site-specific effects on histone H3 modification, including serine 10 phosphorylation important for maintenance of ploidy. Cancer Res 63, 6674-6679.
15. Gandhi, M., Medvedovic, M., Stringer, J. R., and Nikiforov, Y. E. (2006) Interphase chromosome folding determines spatial proximity of genes participating in carcinogenic RET/PTC rearrangements. Oncogene 25, 2360-2366.
16. Chen, K. G., Wang, Y. C., Schaner, M. E., Francisco, B., Duran, G. E., Juric, D., Huff, L. M., Padilla-Nash, H., Ried, T., Fojo, T., and Sikic, B. I. (2005) Genetic and epigenetic modeling of the origins of multidrug-resistant cells in a human sarcoma cell line. Cancer Res 65, 9388-9397.
17. Puccetti, E., Obradovic, D., Beissert, T., Bianchini, A., Washburn, B., Chiaradonna, F., Boehrer, S., Hoelzer, D., Ottmann, O. G., Pelicci, P. G., Nervi, C., and Ruthardt, M. (2002) AML-associated translocation products block vitamin D(3)-induced differentiation by sequestering the vitamin D(3) receptor. Cancer Res 62, 7050-7058.